English 
Español 
Deutsch 
Français 
Italiano 
Nederlands 
Português The L16HTHOUSE study webinar: A drug trial for 16p11.2 deletion
The L16HTHOUSE study webinar: A drug trial for 16p11.2 deletion
Sunday, May 15 | 4:00pm-5:00pm EDT
You’re invited to join a Zoom webinar about the L16HTHOUSE study. L16HTHOUSE is a drug trial for children and adolescents with 16p11.2 deletion. After a long delay related to COVID, the study is about to launch.
Dr. Wendy Chung and Dr. Paul Wang will share information about the study, including the study’s goals, who is eligible, travel requirements, other demands on families who participate, and background on the drug (arbaclofen) that is being studied. There will be plenty of time in the end for questions about the study. This clinical study is only open to US-based, English-speaking participants.
You are invited to submit your questions ahead of time. Please email your questions to ejones@simonsfoundation.org.
Add event the to your calendar
Below is information on how to join the webinar:
https://simonsfoundation.zoom.
Passcode: 567997